Home | Publications | Company Financials place holder

Biotech and Pharma Company Financials

Find reports on the financials of life science companies. Content may include business overview, shares earnings, stock performance history, price and volume figures, dividends, market related data, valuation and revenues.

Stay up-to-date with new products added to this category

place holder place holder place holder place holder place holder place holder

Company Financials


Title Sort Publication Date Sort Price Sort
place holder


British Biologicals -Company Report

February 2008 £375
Bukwang Pharmaceutical Company Limited -Company Report

February 2008 £375
BurnsAdler Pharmaceuticals, Inc. -Company Report

February 2008 £375
Britannia Pharmaceuticals Limited -Company Report

February 2008 £375
Breckenridge Pharmaceutical, Inc. -Company Report

February 2008 £375
Bosnalijek d.d. -Company Report

February 2008 £375
Braintree Laboratories Inc. -Company Report

February 2008 £375
Bravo Healthcare Ltd. -Company Report

February 2008 £375
C&O Pharmaceutical Technology (Holdings) Limited -Company Report

February 2008 £375
CBio Limited -Company Report

February 2008 £375
CLL PHARMA -Company Report

February 2008 £375
COOPER PHARMA -Company Report

February 2008 £375
CORIA Laboratories, Ltd. -Company Report

February 2008 £375
CJ Corp. -Company Report

February 2008 £375
CHO -A Pharmaceutical Company -Company Report

February 2008 £375
CCL Pharmaceuticals -Company Report

February 2008 £375
CEPTYR, Inc. -Company Report

February 2008 £375
Boryung Pharmaceutical Company, Ltd. -Company Report

February 2008 £375
Boram Pharm. Co., Ltd. -Company Report

February 2008 £375
Biotica Technology Limited -Company Report

February 2008 £375
Biotie Therapies Corp. -Company Report

February 2008 £375
Biotron Limited -Company Report

February 2008 £375
Biotherapix SLU -Company Report

February 2008 £375
Biothera. -Company Report

February 2008 £375
Biotec Pharmacon ASA -Company Report

February 2008 £375
Biotest AG -Company Report

February 2008 £375
Biovertis AG -Company Report

February 2008 £375
Biovitrum AB -Company Report

February 2008 £375
Boehringer Ingelheim GmbH -Company Report

February 2008 £375
Bolder BioTechnology, Inc. -Company Report

February 2008 £375
Bone Medical Ltd -Company Report

February 2008 £375
Blue Cross Laboratories, Ltd. -Company Report

February 2008 £375
Blansett Pharmacal Co., Inc. -Company Report

February 2008 £375
Blaine Pharmaceuticals -Company Report

February 2008 £375
Blairex Laboratories, Inc. -Company Report

February 2008 £375
CSC Pharmaceuticals Handels GmbH -Company Report

February 2008 £375
CSL Behring (formerly ZLB Behring) -Company Report

February 2008 £375
China Medical System Holdings Limited -Company Report

February 2008 £375
China National Biotec Group -Company Report

February 2008 £375
Chipscreen Biosciences Ltd -Company Report

February 2008 £375
Chiesi Farmaceutici S.p.A -Company Report

February 2008 £375
Chenho Pharmaceutical Co., Ltd. -Company Report

February 2008 £375
Changchun ChangSheng Gene Pharmaceutical Co., Ltd. -Company Report

February 2008 £375
Changzhou Siyao Pharmaceutical Co., Ltd. -Company Report

February 2008 £375
ChemoCentryx, Inc. -Company Report

February 2008 £375
Chong Kun Dang Pharmaceutical Corp. (CKD Pharm) -Company Report

February 2008 £375
Chongqing -Yaoyou -Pharmaceutical -Company Report

February 2008 £375
Cipla Ltd. -Company Report

February 2008 £375
Circ Pharma Limited -Company Report

February 2008 £375
Cirin Pharmaceuticals (Private) Limited -Company Report

February 2008 £375
Chugai Pharma USA, LLC. -Company Report

February 2008 £375
Chroma Therapeutics Ltd -Company Report

February 2008 £375
Chongqing Tonghe Pharmaceutical CO., LTD -Company Report

February 2008 £375
Choongwae Pharma Corporation -Company Report

February 2008 £375
Ceregene, Inc -Company Report

February 2008 £375
Centrix Pharmaceutical, Inc. -Company Report

February 2008 £375
Can -Fite BioPharma, Ltd. -Company Report

February 2008 £375
Canderm Pharma Inc. -Company Report

February 2008 £375
Cangene Corporation -Company Report

February 2008 £375
Camurus AB -Company Report

February 2008 £375
Cambridge Laboratories -Company Report

February 2008 £375
CSL Limited -Company Report

February 2008 £375
Cambria Biosciences -Company Report

February 2008 £375
Capellon Pharmaceuticals, Ltd. -Company Report

February 2008 £375
Capricorn Pharma, Inc. -Company Report

February 2008 £375
Celon Pharma -Company Report

February 2008 £375
Celtic Pharma -Company Report

February 2008 £375
Centocor, Inc. -Company Report

February 2008 £375
Cellerant Therapeutics, Inc. -Company Report

February 2008 £375
Celldex Therapeutics, Inc -Company Report

February 2008 £375
Cara Therapeutics Inc -Company Report

February 2008 £375
CellGate, Inc -Company Report

February 2008 £375
Biota Holdings Limited -Company Report

February 2008 £375
BiopolyMed Inc. -Company Report

February 2008 £375
ZymoGenetics Inc -Financial Company Report

February 2008 £175
Zynex Medical Holdings Inc -Financial Company Report

February 2008 £175
aRigen Pharmaceuticals, Inc. -Company Report

February 2008 £375
ZymeTx Inc -Financial Company Report

February 2008 £175
Zoll Medical Corporation -Financial Company Report

February 2008 £175
Zaxis International Inc. -Financial Company Report

February 2008 £175
Zila Inc -Financial Company Report

February 2008 £175
Zimmer Holdings Inc -Financial Company Report

February 2008 £175
apex laboratories limited -Company Report

February 2008 £375
axxonis Pharma AG. (formerly NeuroBiotec Pharma AG) -Company Report

February 2008 £375
BIOCODEX -Company Report

February 2008 £375
BIOFARM Sp. z o.o. -Company Report

February 2008 £375
BIOMAX Co. Ltd -Company Report

February 2008 £375
BINEX Co., Ltd -Company Report

February 2008 £375
BETA DERMACEUTICALS, INC. -Company Report

February 2008 £375
bene -Arzneimittel GmbH -Company Report

February 2008 £375
inVentiv Health Inc -Financial Company Report

February 2008 £175
ZIOPHARM Oncology Inc -Financial Company Report

February 2008 £175
Young Innovations Inc -Financial Company Report

February 2008 £175
Wright Medical Group Inc -Financial Company Report

February 2008 £175
WuXi PharmaTech (Cayman) Inc. -Financial Company Report

February 2008 £175
Wyeth -Financial Company Report

February 2008 £175
World Heart Corporation -Financial Company Report

February 2008 £175
Women First Healthcare Inc. -Financial Company Report

February 2008 £175
Wendt -Bristol Health Services -Financial Company Report

February 2008 £175
West Pharmaceuticals Services Inc -Financial Company Report

February 2008 £175
XINO Corp -Financial Company Report

February 2008 £175
XOMA Ltd -Financial Company Report

February 2008 £175
Xenoport Inc -Financial Company Report

February 2008 £175
Xethanol Corp -Financial Company Report

February 2008 £175
YM BioSciences Inc -Financial Company Report

February 2008 £175
Xenomics Inc -Financial Company Report

February 2008 £175
Xechem International Inc. -Financial Company Report

February 2008 £175
XTENT, Inc. -Financial Company Report

February 2008 £175
XTL Biopharmaceuticals Ltd -Financial Company Report

February 2008 £175
BIOMED Wytwornia Surowic i Szczepionek Sp. z o.o. -Company Report

February 2008 £375
BOUTY -Company Report

February 2008 £375
Biochem Pharmaceutical Industries -Company Report

February 2008 £375
Biocompatibles International plc -Company Report

February 2008 £375
Biofarma Pharmaceutical Industry Co. Inc. -Company Report

February 2008 £375
Biocad -Company Report

February 2008 £375
BioXell S.p.A. -Company Report

February 2008 £375
BioVex Inc -Company Report

February 2008 £375
BioWa, Inc. -Company Report

February 2008 £375
Biofrontera AG -Company Report

February 2008 £375
Biokine Therapeutics Ltd. -Company Report

February 2008 £375
Bionaut Pharmaceuticals, Inc. -Company Report

February 2008 £375
Bionomics Limited -Company Report

February 2008 £375
Biopole S.A. -Company Report

February 2008 £375
Biomedica foscama -Company Report

February 2008 £375
Biomedica International -Company Report

February 2008 £375
Biolex Therapeutics -Company Report

February 2008 £375
Biological E. Ltd. -Company Report

February 2008 £375
BioPhausia AB -Company Report

February 2008 £375
BioPartners GmbH -Company Report

February 2008 £375
Bharat Serums And Vaccines Limited -Company Report

February 2008 £375
BiPar Sciences, Inc. -Company Report

February 2008 £375
Bilim Pharmaceuticals -Company Report

February 2008 £375
Bharat Biotech International Limited -Company Report

February 2008 £375
Beximco Pharmaceuticals Ltd. -Company Report

February 2008 £375
BTG plc -Company Report

February 2008 £375
BestoChem Formulations (I) Ltd -Company Report

February 2008 £375
Bio -Pharm, Inc. -Company Report

February 2008 £375
Bio3 Research -Company Report

February 2008 £375
BioInvent International AB -Company Report

February 2008 £375
BioLineRx, Ltd. -Company Report

February 2008 £375
BioNumerik Pharmaceuticals, Inc. -Company Report

February 2008 £375
BioCore Medical Technologies, Inc. -Company Report

February 2008 £375
BioCancell Therapeutics, Inc. -Company Report

February 2008 £375
BioAlliance Pharma -Company Report

February 2008 £375
BioAxone Therapeutic Inc. -Company Report

February 2008 £375
Claris Lifesciences Limited -Company Report

February 2008 £375
Clavis Pharma ASA -Company Report

February 2008 £375
Elite Pharma Pvt. Ltd. -Company Report

February 2008 £375
Elixir Pharmaceuticals, Inc. -Company Report

February 2008 £375
Embil Pharmaceutical Co. Ltd. -Company Report

February 2008 £375
Elder Pharmaceuticals Ltd -Company Report

February 2008 £375
Egyptian Co. for Chemicals & Pharmaceuticals S.A.E. (ADWIA) -Company Report

February 2008 £375
EVIT Labs, Inc. -Company Report

February 2008 £375
East India Pharmaceutical Works Limited -Company Report

February 2008 £375
Efroze Chemical Industries -Company Report

February 2008 £375
Emcure Pharmaceuticals Ltd. -Company Report

February 2008 £375
EnVivo Pharmaceuticals -Company Report

February 2008 £375
EpiGenesis Pharmaceuticals Inc -Company Report

February 2008 £375
Epla Laboratories (Pvt.) Ltd. -Company Report

February 2008 £375
Erimos Pharmaceuticals -Company Report

February 2008 £375
Epeius Biotechnologies Corp -Company Report

February 2008 £375
Entegrion, Inc. -Company Report

February 2008 £375
Enaleni Pharmaceuticals Ltd -Company Report

February 2008 £375
Endocyte, Inc. -Company Report

February 2008 £375
EUSA Pharma Inc. -Company Report

February 2008 £375
ESPEFA -Company Report

February 2008 £375
DynPort Vaccine Company LLC -Company Report

February 2008 £375
Dynapharm (M) Sdn. Bhd. -Company Report

February 2008 £375
Dynogen Pharmaceuticals, Inc. -Company Report

February 2008 £375
DrugAbuse Sciences, Inc. -Company Report

February 2008 £375
Drug Houses of Australia (Asia) Pte. Ltd. -Company Report

February 2008 £375
Drogsan Pharmaceuticals -Company Report

February 2008 £375
Drossapharm Ltd -Company Report

February 2008 £375
EBEWE Pharma Ges.m.b.H. Nfg.KG -Company Report

February 2008 £375
ECR Pharmaceuticals -Company Report

February 2008 £375
ENT Technologies PTY LTD -Company Report

February 2008 £375
ENTOD PHARMACEUTICALS LTD. -Company Report

February 2008 £375
ERYtech Pharma -Company Report

February 2008 £375
ENKAM Pharmaceutical A/S -Company Report

February 2008 £375
ELSaad Pharmaceutical Industries -Company Report

February 2008 £375
EGIS Pharmaceuticals PLC -Company Report

February 2008 £375
ELPEN Pharmaceutical Co. Inc. -Company Report

February 2008 £375
Errant Gene Therapeutics, LLC -Company Report

February 2008 £375
Eskayef Bangladesh Limited -Company Report

February 2008 £375
FDC Ltd. -Company Report

February 2008 £375
FIT Biotech Oyj Plc. -Company Report

February 2008 £375
FRANCO -INDIAN PHARMACEUTICALS PVT. LTD. -Company Report

February 2008 £375
elbion NV -Company Report

February 2008 £375
e -Therapeutics -Company Report

February 2008 £375
biosyn Corporation -Company Report

February 2008 £375
curasan AG -Company Report

February 2008 £375
FSP GALENA -Company Report

February 2008 £375
Faust Pharmaceuticals -Company Report

February 2008 £375
FibroGen, Inc. -Company Report

February 2008 £375
Fidia farmaceutici S.p.A. -Company Report

February 2008 £375
FivePrime Therapeutics, Inc. -Company Report

February 2008 £375
Fertin Pharma A/S -Company Report

February 2008 £375
Ferring Pharmaceuticals A/S -Company Report

February 2008 £375
Ferndale Laboratories, Inc. -Company Report

February 2008 £375
Ferozsons Laboratories Limited -Company Report

February 2008 £375
Faron Pharmaceuticals Ltd. -Company Report

February 2008 £375
Farmoquimica S/A -Company Report

February 2008 £375
Eurodrug Laboratories -Company Report

February 2008 £375
Everett Laboratories, Inc. -Company Report

February 2008 £375
Evolutec Group plc -Company Report

February 2008 £375
Euphoric Pharmaceuticals (P) Ltd -Company Report

February 2008 £375
Ethypharm SA -Company Report

February 2008 £375
Essex Bio -Technology Limited -Company Report

February 2008 £375
Esteve -Company Report

February 2008 £375
Evotec AG -Company Report

February 2008 £375
ExonHit Therapeutics SA -Company Report

February 2008 £375
Fabre -Kramer Pharmaceuticals, Inc. -Company Report

February 2008 £375
Falcon Pharmaceuticals, Ltd. -Company Report

February 2008 £375
Farmacija d.o.o. -Company Report

February 2008 £375
FASgen, Inc. -Company Report

February 2008 £375
FARAN LABORATORIES sa -Company Report

February 2008 £375
Expression Genetics, Inc. -Company Report

February 2008 £375
FAES FARMA -Company Report

February 2008 £375
Dr. Kade Pharmazeutische Fabrik GmbH -Company Report

February 2008 £375
Dr. Falk Pharma GmbH -Company Report

February 2008 £375
Cygnus Healthcare Specialities Pvt. Ltd. -Company Report

February 2008 £375
CytImmune Sciences, Inc. -Company Report

February 2008 £375
Cytheris SA -Company Report

February 2008 £375
CyDex Pharmaceuticals, Inc. -Company Report

February 2008 £375
Curalogic A/S -Company Report

February 2008 £375
Crimson Pharma -Company Report

February 2008 £375
Cumberland Pharmaceuticals Inc. -Company Report

February 2008 £375
Curacyte AG -Company Report

February 2008 £375
Cytochroma Inc. -Company Report

February 2008 £375
Cytokine PharmaSciences Inc. -Company Report

February 2008 £375
DAVA Pharmaceuticals, Inc. -Company Report

February 2008 £375
DAWA Limited -Company Report

February 2008 £375
DEY L.P. -Company Report

February 2008 £375
DARA BioSciences, Inc. -Company Report

February 2008 £375
DAIICHI SANKYO COMPANY, LIMITED -Company Report

February 2008 £375
Cytopia -Company Report

February 2008 £375
D -Pharm Ltd -Company Report

February 2008 £375
Creabilis Therapeutics SPA -Company Report

February 2008 £375
Crawford Pharmaceuticals -Company Report

February 2008 £375
CoMentis, Inc. -Company Report

February 2008 £375
Cobalt Pharmaceuticals -Company Report

February 2008 £375
Colby Pharmaceutical Company -Company Report

February 2008 £375
CoGenesys, Inc. -Company Report

February 2008 £375
Co -pharma Limited -Company Report

February 2008 £375
Clera Inc. -Company Report

February 2008 £375
Clonmel Healthcare Ltd. -Company Report

February 2008 £375
Collegium Pharmaceutical, Inc. -Company Report

February 2008 £375
Coloplast AS -Company Report

February 2008 £375
ConjuChem Inc. -Company Report

February 2008 £375
Cornerstone BioPharma, Inc. -Company Report

February 2008 £375
Cosmo Pharmaceuticals S.p.A. -Company Report

February 2008 £375
Concert Pharmaceuticals, Inc. -Company Report

February 2008 £375
Concept Pharmaceuticals Ltd. -Company Report

February 2008 £375
Combino Pharm -Company Report

February 2008 £375
Combiphar -Company Report

February 2008 £375
DMI BioSciences, Inc. -Company Report

February 2008 £375
DNAVEC Corporation -Company Report

February 2008 £375
DiaMedica Inc. -Company Report

February 2008 £375
Diabetology Ltd -Company Report

February 2008 £375
Diatos SA -Company Report

February 2008 £375
DiaKine Therapeutics, Inc. -Company Report

February 2008 £375
Dexcel Pharma Technologies Ltd. -Company Report

February 2008 £375
DeveloGen AG -Company Report

February 2008 £375
DexGen Pharmaceuticals, Inc. -Company Report

February 2008 £375
Diffusion Pharmaceuticals LLC -Company Report

February 2008 £375
Digna Biotech, S.L. -Company Report

February 2008 £375